Cefuroxime (2nd Gen) Injectable (iv, Im) Generics - Manufacturers & Suppliers
Ceftin, Zinacef(US & EU)
| Product/Composition:- | Cefuroxime (2nd Gen) Injectable (IV, IM) |
|---|---|
| Strength:- | 750 mg, 1.5 g, 3 g |
| Form:- | Injectable (IV, IM) |
| Reference Brands:- | Ceftin, Zinacef(US & EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Cefuroxime injectable binds to bacterial penicillin-binding proteins, inhibiting cell wall synthesis and causing bacterial lysis. It is effective against severe respiratory, urinary, and skin infections. Benefits include rapid, reliable bacterial eradication, broad-spectrum activity, good tissue penetration, and suitability for inpatient use, providing effective treatment for serious bacterial infections.
Cefuroxime injectable, a 2nd generation cephalosporin, is approved in the EU and US for severe bacterial infections. In the EU, brands like Zinacef are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval relies on extensive clinical data, with generic options available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and continuous safety monitoring. Due to its critical use, strict regulations on storage, labeling, and administration are enforced. For regulatory support, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for cefuroxime injections adhering to European and US standards.